Dianthus Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Dianthus Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-07 | $-0.74 | $-0.61 | -21.3 % |
Jun 2024 | 2024-08-08 | $-0.51 | $-0.55 | 7.27 % |
Mar 2024 | 2024-05-09 | $-0.54 | $-0.44 | -22.7 % |
Dec 2023 | 2024-03-21 | $-0.71 | $-1.01 | 29.7 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-07 | $2.17M | $600.00K | 262.0 % |
Jun 2024 | 2024-08-08 | $1.86M | $322.75K | 477.2 % |
Mar 2024 | 2024-05-09 | $874.00K | $460.00K | 90.0 % |
Dec 2023 | 2024-03-21 | $457.00K | $310.00K | 47.4 % |
Dianthus Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2024 for Q3.
Dianthus Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2024 for Q3 and the Actual EPS was $-0.74, which missed the estimate of $-0.61.
Dianthus Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which beat the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.